Drug Profile
Pancratistatin analogues - Egis
Latest Information Update: 15 Aug 2007
Price :
$50
*
At a glance
- Originator Egis Pharmaceuticals
- Class
- Mechanism of Action Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Viral infections
Most Recent Events
- 25 Sep 1997 New profile
- 25 Sep 1997 Preclinical development for Cancer in Hungary (Unknown route)
- 25 Sep 1997 Preclinical development for Viral infections in Hungary (Unknown route)